Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling.

Toll-like receptors (TLRs) recognize distinct microbial components to initiate the innate and adaptive immune responses. TLR activation culminates in the expression of appropriate pro-inflammatory and immunomodulatory factors to meet pathogenic challenges. The transcription factor NF-kappaB is the master regulator of all TLR-induced responses and its activation is the pivotal event in TLR-mediated activation of the innate immune response. Many of the key molecular events required for TLR-induced NF-kappaB activation have been elucidated. However, much remains to be learned about the ability of TLRs to generate pathogen-specific responses using a limited number of transcription factors. This review will focus on our current understanding of NF-kappaB activation by TLRs and potential mechanisms for achieving a signal-specific response through NF-kappaB.

[1]  M. Toruner,et al.  NF‐κB Signaling , 2006 .

[2]  M. Daucher,et al.  Activation of the serum response factor by p65/NF‐kappaB. , 1996, The EMBO journal.

[3]  D. Schwartz,et al.  Toll-like receptors in the pathogenesis of human disease , 2004, Nature Immunology.

[4]  Zhijian J. Chen,et al.  TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. , 2004, Molecular cell.

[5]  R. Gaynor,et al.  Regulation of IκB Kinase (IKK)γ/NEMO Function by IKKβ-mediated Phosphorylation* , 2002, The Journal of Biological Chemistry.

[6]  Honglin Zhou,et al.  Bcl10 activates the NF-κB pathway through ubiquitination of NEMO , 2004, Nature.

[7]  D. Wallach,et al.  If the prophet does not come to the mountain: dynamics of signaling complexes in NF-kappaB activation. , 2006, Molecular cell.

[8]  Y. Xiong,et al.  A Role for NF-κB Essential Modifier/IκB Kinase-γ (NEMO/IKKγ) Ubiquitination in the Activation of the IκB Kinase Complex by Tumor Necrosis Factor-α* , 2003, Journal of Biological Chemistry.

[9]  G. Nabel,et al.  A cooperative interaction between NF‐kappa B and Sp1 is required for HIV‐1 enhancer activation. , 1993, The EMBO journal.

[10]  H. Erdjument-Bromage,et al.  IκB-β regulates the persistent response in a biphasic activation of NF-κB , 1995, Cell.

[11]  T. Mak,et al.  Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4 , 2002, Nature.

[12]  J. Inoue,et al.  Bcl-3, a member of the I kappa B proteins, has distinct specificity towards the Rel family of proteins. , 1993, Oncogene.

[13]  M. Merville,et al.  Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation , 2005 .

[14]  C. Mirtsos,et al.  The Role of Interleukin 1 Receptor-associated Kinase-4 (IRAK-4) Kinase Activity in IRAK-4-mediated Signaling* , 2004, Journal of Biological Chemistry.

[15]  Michael Karin,et al.  Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation , 1999 .

[16]  S. Akira,et al.  Toll-like receptors in innate immunity. , 2004, International immunology.

[17]  B. Williams,et al.  Poly(dI·dC)-induced Toll-like Receptor 3 (TLR3)-mediated Activation of NFκB and MAP Kinase Is through an Interleukin-1 Receptor-associated Kinase (IRAK)-independent Pathway Employing the Signaling Components TLR3-TRAF6-TAK1-TAB2-PKR* , 2003, The Journal of Biological Chemistry.

[18]  Richard A. Young,et al.  Insights into host responses against pathogens from transcriptional profiling , 2005, Nature Reviews Microbiology.

[19]  S. Miyamoto,et al.  Expanded Nuclear Roles for IκBs , 2004, Science's STKE.

[20]  H. Kuwata,et al.  IkappaBNS inhibits induction of a subset of Toll-like receptor-dependent genes and limits inflammation. , 2006, Immunity.

[21]  A. Baldwin,et al.  Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. , 1993, Molecular and cellular biology.

[22]  Douglas K. Miller,et al.  The Interleukin-1 Receptor-associated Kinase Is Degraded by Proteasomes following Its Phosphorylation* , 1997, The Journal of Biological Chemistry.

[23]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[24]  Y. You,et al.  Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation* , 2006, Journal of Biological Chemistry.

[25]  W C Greene,et al.  NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. , 1993, Science.

[26]  Y. Kadono,et al.  Segregation of TRAF6‐mediated signaling pathways clarifies its role in osteoclastogenesis , 2001, The EMBO journal.

[27]  S. Akira,et al.  Essential function for the kinase TAK1 in innate and adaptive immune responses , 2005, Nature Immunology.

[28]  Matthew T Wheeler,et al.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.

[29]  Leonard Buckbinder,et al.  NF-κB RelA Phosphorylation Regulates RelA Acetylation , 2005, Molecular and Cellular Biology.

[30]  K. Ishii,et al.  Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling , 2006, Nature Immunology.

[31]  S. Ghosh,et al.  Regulating Inducible Transcription Through Controlled Localization , 2005, Science's STKE.

[32]  E. Reinherz,et al.  Peptide-Induced Negative Selection of Thymocytes Activates Transcription of an NF-ΚB Inhibitor , 2002 .

[33]  S. Gerondakis,et al.  Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models , 2006, Oncogene.

[34]  Fan Yang,et al.  IKKβ Plays an Essential Role in the Phosphorylation of RelA/p65 on Serine 536 Induced by Lipopolysaccharide1 , 2003, The Journal of Immunology.

[35]  S. Akira,et al.  Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes1 , 2001, The Journal of Immunology.

[36]  E. Zandi,et al.  The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.

[37]  H. Erdjument-Bromage,et al.  The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP–Independent Mechanism , 1997, Cell.

[38]  H. Sakurai,et al.  TGF-beta-activated kinase 1 stimulates NF-kappa B activation by an NF-kappa B-inducing kinase-independent mechanism. , 1998, Biochemical and biophysical research communications.

[39]  P. Dobrzanski,et al.  Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100. , 1995, Oncogene.

[40]  E. Zandi,et al.  IKK-γ is an essential regulatory subunit of the IκB kinase complex , 1998, Nature.

[41]  L. Cantley,et al.  The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMO , 2004, Current Biology.

[42]  Michael Karin,et al.  Regulation and Function of IKK and IKK-Related Kinases , 2006, Science's STKE.

[43]  M. Hardy,et al.  The Murine Irak2 Gene Encodes Four Alternatively Spliced Isoforms, Two of Which Are Inhibitory* , 2004, Journal of Biological Chemistry.

[44]  M. May A Nuclear Factor in B Cells and Beyond , 2006, The Journal of Immunology.

[45]  S. Akira,et al.  Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ , 2004, Nature.

[46]  S. Ghosh,et al.  Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex , 2000 .

[47]  Toby Lawrence,et al.  IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation , 2005, Nature.

[48]  B. Lemaître,et al.  Mutations in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel/NF-kappaB-dependent innate immune responses. , 2001, Genes & development.

[49]  W. Tam,et al.  Cytoplasmic Sequestration of Rel Proteins by IκBα Requires CRM1-Dependent Nuclear Export , 2000, Molecular and Cellular Biology.

[50]  E. Dejardin The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development. , 2006, Biochemical pharmacology.

[51]  Joshua M. Korn,et al.  The plasticity of dendritic cell responses to pathogens and their components. , 2001, Science.

[52]  Ash A. Alizadeh,et al.  Stereotyped and specific gene expression programs in human innate immune responses to bacteria , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Sankar Ghosh,et al.  Negative Regulation of Toll-like Receptor-mediated Signaling by Tollip* , 2002, The Journal of Biological Chemistry.

[54]  A. Bowie,et al.  The human adaptor SARM negatively regulates adaptor protein TRIF–dependent Toll-like receptor signaling , 2006, Nature Immunology.

[55]  F. Martinon,et al.  RIP1 is an essential mediator of Toll-like receptor 3–induced NF-κB activation , 2004, Nature Immunology.

[56]  S. Srinivasula,et al.  Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation , 2006, Nature Cell Biology.

[57]  E. Lander,et al.  Human macrophage activation programs induced by bacterial pathogens , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Zhijian J. Chen,et al.  Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.

[59]  R. Tibbetts,et al.  Molecular Linkage Between the Kinase ATM and NF-κB Signaling in Response to Genotoxic Stimuli , 2006, Science.

[60]  Takahiro Doi,et al.  Tumor Necrosis Factor-α-induced IKK Phosphorylation of NF-κB p65 on Serine 536 Is Mediated through the TRAF2, TRAF5, and TAK1 Signaling Pathway* , 2003, Journal of Biological Chemistry.

[61]  Somasekar Seshagiri,et al.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.

[62]  Shizuo Akira,et al.  Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-β (TRIF) Associates with TNF Receptor-Associated Factor 6 and TANK-Binding Kinase 1, and Activates Two Distinct Transcription Factors, NF-κB and IFN-Regulatory Factor-3, in the Toll-Like Receptor Signaling 1 , 2003, The Journal of Immunology.

[63]  S. Akira,et al.  TRAM is specifically involved in the Toll-like receptor 4–mediated MyD88-independent signaling pathway , 2003, Nature Immunology.

[64]  G Cantarella,et al.  Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. , 2000, Immunity.

[65]  J. Orange,et al.  Interleukin-1-induced NF-κB Activation Is NEMO-dependent but Does Not Require IKKβ* , 2007, Journal of Biological Chemistry.

[66]  Alexander Hoffmann,et al.  Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity , 2005, Science.

[67]  A. Shevchenko,et al.  Activation of Transcription Factor NF-κB Requires ELKS, an IκB Kinase Regulatory Subunit , 2004, Science.

[68]  G. Mosialos,et al.  v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence. , 1993, Oncogene.

[69]  A. Baldwin,et al.  Activation of Nuclear Factor-κB-dependent Transcription by Tumor Necrosis Factor-α Is Mediated through Phosphorylation of RelA/p65 on Serine 529* , 1998, The Journal of Biological Chemistry.

[70]  K. N. Pennington,et al.  In Vivo Identification of Inducible Phosphoacceptors in the IKKγ/NEMO Subunit of Human IκB Kinase* , 2003, Journal of Biological Chemistry.

[71]  Jiahuai Han,et al.  Limiting inflammatory responses during activation of innate immunity , 2005, Nature Immunology.

[72]  T. Maniatis,et al.  Immune Activation of NF-κB and JNK Requires Drosophila TAK1* , 2003, Journal of Biological Chemistry.

[73]  Zhijian J. Chen,et al.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK , 2001, Nature.

[74]  S. Ghosh,et al.  The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1 , 2002 .

[75]  W. Greene,et al.  p53 Induces NF-κB Activation by an IκB Kinase-independent Mechanism Involving Phosphorylation of p65 by Ribosomal S6 Kinase 1* , 2004, Journal of Biological Chemistry.

[76]  S. Dower,et al.  Activation of Nuclear Transcription Factor NF-κB by Interleukin-1 Is Accompanied by Casein Kinase II-mediated Phosphorylation of the p65 Subunit* , 1997, The Journal of Biological Chemistry.

[77]  Alexander Hoffmann,et al.  IκBɛ provides negative feedback to control NF-κB oscillations, signaling dynamics, and inflammatory gene expression , 2006, The Journal of cell biology.

[78]  Tak W. Mak,et al.  Toll-like receptor 3-mediated activation of NF-κB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-β , 2004 .

[79]  Daniel R. Caffrey,et al.  LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF , 2003, The Journal of experimental medicine.

[80]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[81]  W. Greene,et al.  Cross‐coupling of the NF‐kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. , 1993, The EMBO journal.

[82]  W. Liao,et al.  NFκB Interacts with Serum Amyloid A3 Enhancer Factor to Synergistically Activate Mouse Serum Amyloid A3 Gene Transcription* , 2000, The Journal of Biological Chemistry.

[83]  S. Akira,et al.  IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-α production in macrophages , 2003 .

[84]  Inder M. Verma,et al.  Enhanced NF-κB activation and cellular function in macrophages lacking IκB kinase 1 (IKK1) , 2005 .

[85]  B. Seed,et al.  RIP mediates tumor necrosis factor receptor 1 activation of NF‐kappaB but not Fas/APO‐1‐initiated apoptosis. , 1996, The EMBO journal.

[86]  C. Ambrosino,et al.  Regulation of HIV-1 Long Terminal Repeats by Interaction of C/EBP(NF-IL6) and NF-κB/Rel Transcription Factors* , 1996, The Journal of Biological Chemistry.

[87]  A. Hoffmann,et al.  Molecular Determinants of Crosstalk between Nuclear Receptors and Toll-like Receptors , 2005, Cell.

[88]  S. Akira,et al.  Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling1 , 2002, The Journal of Immunology.

[89]  Eric Verdin,et al.  Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation , 2001, Science.

[90]  W. Greene,et al.  A novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization , 1993, Molecular and cellular biology.

[91]  C. Sardet,et al.  Post-activation Turn-off of NF-κB-dependent Transcription Is Regulated by Acetylation of p65* , 2003, The Journal of Biological Chemistry.

[92]  Govinda Rao,et al.  IRF3 mediates a TLR3/TLR4-specific antiviral gene program. , 2002, Immunity.

[93]  P. Cohen,et al.  TAB3, a new binding partner of the protein kinase TAK1. , 2004, The Biochemical journal.

[94]  N. Perkins Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway , 2006, Oncogene.

[95]  J. Knop,et al.  Effects of IL‐1 receptor‐associated kinase (IRAK) expression on IL‐1 signaling are independent of its kinase activity , 1999, FEBS letters.

[96]  R. Gaynor,et al.  Role of the TAB2‐related protein TAB3 in IL‐1 and TNF signaling , 2003, The EMBO journal.

[97]  J. Stavnezer,et al.  Interaction of Stat6 and NF-κB: Direct Association and Synergistic Activation of Interleukin-4-Induced Transcription , 1998, Molecular and Cellular Biology.

[98]  K. Burns,et al.  Inhibition of Interleukin 1 Receptor/Toll-like Receptor Signaling through the Alternatively Spliced, Short Form of MyD88 Is Due to Its Failure to Recruit IRAK-4 , 2003, The Journal of experimental medicine.

[99]  Ki-Young Lee,et al.  TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. , 2005, Genes & development.

[100]  J. Inoue,et al.  Cutting Edge: TNFR-Associated Factor (TRAF) 6 Is Essential for MyD88-Dependent Pathway but Not Toll/IL-1 Receptor Domain-Containing Adaptor-Inducing IFN-β (TRIF)-Dependent Pathway in TLR Signaling1 , 2004, Journal of Immunology.

[101]  J. Casanova,et al.  IRAK4 Kinase Activity Is Redundant for Interleukin-1 (IL-1) Receptor-associated Kinase Phosphorylation and IL-1 Responsiveness* , 2004, Journal of Biological Chemistry.

[102]  G. Stark,et al.  Mutant Cells That Do Not Respond to Interleukin-1 (IL-1) Reveal a Novel Role for IL-1 Receptor-Associated Kinase , 1999, Molecular and Cellular Biology.

[103]  T. Muta IκB‐ζ: An Inducible Regulator of Nuclear Factor‐κB , 2006 .

[104]  G. Nabel,et al.  An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation , 1994, Molecular and cellular biology.

[105]  W. Greene,et al.  Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF‐κB , 2002, The EMBO journal.

[106]  D. Baltimore,et al.  A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB. , 1989, Genes & development.

[107]  S. Westerheide,et al.  Tumor Necrosis Factor α-induced Phosphorylation of RelA/p65 on Ser529 Is Controlled by Casein Kinase II* , 2000, The Journal of Biological Chemistry.

[108]  M. Mann,et al.  Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6 , 2006, Nature.

[109]  Michael Karin,et al.  NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.

[110]  H. Young,et al.  BCL-3 and NF-κB p50 Attenuate Lipopolysaccharide-induced Inflammatory Responses in Macrophages* , 2004, Journal of Biological Chemistry.

[111]  F. Liew,et al.  Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.

[112]  S. Miyamoto,et al.  Sequential Modification of NEMO/IKKγ by SUMO-1 and Ubiquitin Mediates NF-κB Activation by Genotoxic Stress , 2003, Cell.

[113]  J. Ninomiya-Tsuji,et al.  The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway , 1999, Nature.

[114]  S. Ruben,et al.  I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. , 1992, Genes & development.

[115]  S. Gerondakis,et al.  Alternative splicing of RNA transcripts encoded by the murine p105 NF-kappa B gene generates I kappa B gamma isoforms with different inhibitory activities. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[116]  G. Courtois,et al.  Posttranslational modifications of NEMO and its partners in NF-κB signaling , 2006 .

[117]  C. Jefferies,et al.  Interferon Regulatory Factor-3-mediated Activation of the Interferon-sensitive Response Element by Toll-like receptor (TLR) 4 but Not TLR3 Requires the p65 Subunit of NF-κ* , 2003, Journal of Biological Chemistry.

[118]  J. Swantek,et al.  IL-1 Receptor-Associated Kinase Modulates Host Responsiveness to Endotoxin1 , 2000, The Journal of Immunology.

[119]  S. Saccani,et al.  Degradation of Promoter-bound p65/RelA Is Essential for the Prompt Termination of the Nuclear Factor κB Response , 2004, The Journal of experimental medicine.

[120]  F. Kashanchi,et al.  Enhancement of Nuclear Factor-κB Acetylation by Coactivator p300 and HIV-1 Tat Proteins* , 2002, The Journal of Biological Chemistry.

[121]  A. Israël,et al.  I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF‐κB activity , 1997 .

[122]  Gerard J. Nau,et al.  Cumulative Toll-Like Receptor Activation in Human Macrophages Treated with Whole Bacteria1 , 2003, The Journal of Immunology.

[123]  H. Sakurai,et al.  IκB Kinases Phosphorylate NF-κB p65 Subunit on Serine 536 in the Transactivation Domain* , 1999, The Journal of Biological Chemistry.